Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant
Clinical trial NCT01930162 · COMPLETED
Trial details
- NCT number
- NCT01930162
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-07
- Primary completion
- 2016-08-29
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.